Citigroup’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-75,600
| Closed | -$6.43M | – | 7806 |
|
|
2020
Q3 | $6.43M | Buy |
75,600
+23,000
| +44% | +$1.16M | ﹤0.01% | 1717 |
|
|
2020
Q2 | $1.86M | Buy |
52,600
+12,500
| +31% | +$365K | ﹤0.01% | 2890 |
|
|
2020
Q1 | $541K | Sell |
40,100
-39,400
| -50% | -$663K | ﹤0.01% | 3806 |
|
|
2019
Q4 | $1.68M | Sell |
79,500
-7,700
| -9% | -$136K | ﹤0.01% | 3187 |
|
|
2019
Q3 | $1.16M | Buy |
87,200
+40,100
| +85% | +$589K | ﹤0.01% | 3483 |
|
|
2019
Q2 | $653K | Sell |
47,100
-22,300
| -32% | -$336K | ﹤0.01% | 4148 |
|
|
2019
Q1 | $1.33M | Sell |
69,400
-27,300
| -28% | -$440K | ﹤0.01% | 3082 |
|
|
2018
Q4 | $1.38M | Buy |
96,700
+32,900
| +52% | +$653K | ﹤0.01% | 3058 |
|
|
2018
Q3 | $1.33M | Buy |
63,800
+43,100
| +208% | +$1.02M | ﹤0.01% | 3167 |
|
|
2018
Q2 | $490K | Sell |
20,700
-16,700
| -45% | -$336K | ﹤0.01% | 4137 |
|
|
2018
Q1 | $546K | Sell |
37,400
-225,200
| -86% | -$3.68M | ﹤0.01% | 3888 |
|
|
2017
Q4 | $4.24M | Buy |
262,600
+225,700
| +612% | +$2.66M | ﹤0.01% | 1987 |
|
|
2017
Q3 | $516K | Sell |
36,900
-1,800
| -5% | -$17.9K | ﹤0.01% | 4094 |
|
|
2017
Q2 | $342K | Buy |
38,700
+9,500
| +33% | +$66.7K | ﹤0.01% | 4341 |
|
|
2017
Q1 | $189K | Buy |
29,200
+19,900
| +214% | +$101K | ﹤0.01% | 4706 |
|
|
2016
Q4 | $34K | Buy |
9,300
+7,800
| +520% | +$23.1K | ﹤0.01% | 6320 |
|
|
2016
Q3 | $5K | Sell |
1,500
-1,000
| -40% | -$2.8K | ﹤0.01% | 6797 |
|
|
2016
Q2 | $6K | Sell |
2,500
-7,500
| -75% | -$25.1K | ﹤0.01% | 6740 |
|
|
2016
Q1 | $25K | Hold |
10,000
| – | – | ﹤0.01% | 6463 |
|
|
2015
Q4 | $31K | Buy |
+10,000
| New | +$27.9K | ﹤0.01% | 6252 |
|
|
2015
Q3 | – | Sell |
-1,200
| Closed | -$5K | – | 7913 |
|
|
2015
Q2 | $5K | Buy |
+1,200
| New | +$4.91K | ﹤0.01% | 6798 |
|
Citigroup's IMMU Position: Q4 2020 in Review
Citigroup sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 568,440 shares — an estimated $48.3M sold.
Citigroup first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $48.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Citigroup reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Citigroup sold 568,440 Immunomedics Inc shares in Q4 2020, an estimated $48.3M.
- Citigroup first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
- Citigroup's Immunomedics Inc position peaked at $48.3M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Citigroup's 13F filing for Q4 2020, filed 11 Feb 2021.